CA2755207A1 - Reagents and methods for pcr - Google Patents
Reagents and methods for pcr Download PDFInfo
- Publication number
- CA2755207A1 CA2755207A1 CA2755207A CA2755207A CA2755207A1 CA 2755207 A1 CA2755207 A1 CA 2755207A1 CA 2755207 A CA2755207 A CA 2755207A CA 2755207 A CA2755207 A CA 2755207A CA 2755207 A1 CA2755207 A1 CA 2755207A1
- Authority
- CA
- Canada
- Prior art keywords
- additive
- primer
- amplification
- stranded
- double
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims description 39
- 239000003153 chemical reaction reagent Substances 0.000 title claims description 36
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 330
- 230000003321 amplification Effects 0.000 claims abstract description 329
- 238000006243 chemical reaction Methods 0.000 claims abstract description 249
- 108091034117 Oligonucleotide Proteins 0.000 claims abstract description 142
- 239000011541 reaction mixture Substances 0.000 claims abstract description 133
- 239000002773 nucleotide Substances 0.000 claims abstract description 101
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 95
- 230000000694 effects Effects 0.000 claims abstract description 77
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims abstract description 76
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims abstract description 76
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims abstract description 69
- 238000002844 melting Methods 0.000 claims abstract description 57
- 230000008018 melting Effects 0.000 claims abstract description 54
- 108010010677 Phosphodiesterase I Proteins 0.000 claims abstract description 33
- 230000001419 dependent effect Effects 0.000 claims abstract description 28
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 23
- 230000001965 increasing effect Effects 0.000 claims abstract description 22
- 230000004544 DNA amplification Effects 0.000 claims abstract description 10
- 239000000654 additive Substances 0.000 claims description 659
- 230000000996 additive effect Effects 0.000 claims description 486
- WCKQPPQRFNHPRJ-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]diazenyl]benzoic acid Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=C(C(O)=O)C=C1 WCKQPPQRFNHPRJ-UHFFFAOYSA-N 0.000 claims description 275
- 239000000523 sample Substances 0.000 claims description 188
- 238000003556 assay Methods 0.000 claims description 106
- 230000000295 complement effect Effects 0.000 claims description 102
- 238000000137 annealing Methods 0.000 claims description 99
- 238000012408 PCR amplification Methods 0.000 claims description 95
- 239000000203 mixture Substances 0.000 claims description 83
- 238000003752 polymerase chain reaction Methods 0.000 claims description 71
- 239000003607 modifier Substances 0.000 claims description 64
- 238000001514 detection method Methods 0.000 claims description 54
- 230000002441 reversible effect Effects 0.000 claims description 34
- 238000009396 hybridization Methods 0.000 claims description 19
- 230000006872 improvement Effects 0.000 claims description 12
- 125000003367 polycyclic group Chemical group 0.000 claims description 11
- 102100034343 Integrase Human genes 0.000 claims description 9
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims description 9
- 238000001917 fluorescence detection Methods 0.000 claims description 9
- 239000013615 primer Substances 0.000 description 447
- 239000000047 product Substances 0.000 description 189
- 230000000670 limiting effect Effects 0.000 description 117
- 108010006785 Taq Polymerase Proteins 0.000 description 48
- 238000011534 incubation Methods 0.000 description 38
- 239000000155 melt Substances 0.000 description 37
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 35
- 108091093088 Amplicon Proteins 0.000 description 28
- 238000002944 PCR assay Methods 0.000 description 26
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 24
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 22
- 108020004414 DNA Proteins 0.000 description 22
- 102000053602 DNA Human genes 0.000 description 22
- 230000005764 inhibitory process Effects 0.000 description 22
- 238000004458 analytical method Methods 0.000 description 21
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 20
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 20
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 20
- 239000000872 buffer Substances 0.000 description 17
- 150000007523 nucleic acids Chemical class 0.000 description 17
- 230000002829 reductive effect Effects 0.000 description 17
- 102000039446 nucleic acids Human genes 0.000 description 16
- 108020004707 nucleic acids Proteins 0.000 description 16
- 230000001629 suppression Effects 0.000 description 16
- 238000012163 sequencing technique Methods 0.000 description 15
- 238000003776 cleavage reaction Methods 0.000 description 14
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 14
- 230000015572 biosynthetic process Effects 0.000 description 12
- 229910052697 platinum Inorganic materials 0.000 description 12
- 230000007017 scission Effects 0.000 description 12
- 238000005382 thermal cycling Methods 0.000 description 12
- 108700028369 Alleles Proteins 0.000 description 10
- 238000013211 curve analysis Methods 0.000 description 10
- 239000000539 dimer Substances 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 10
- 108060002716 Exonuclease Proteins 0.000 description 9
- 229910052799 carbon Inorganic materials 0.000 description 9
- 239000002299 complementary DNA Substances 0.000 description 9
- 102000013165 exonuclease Human genes 0.000 description 9
- 239000003112 inhibitor Substances 0.000 description 9
- 230000004048 modification Effects 0.000 description 9
- 238000012986 modification Methods 0.000 description 9
- 239000002987 primer (paints) Substances 0.000 description 9
- 230000037452 priming Effects 0.000 description 9
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 8
- MTVVRWVOXZSVBW-UHFFFAOYSA-M QSY21 succinimidyl ester Chemical compound [Cl-].C1CN(S(=O)(=O)C=2C(=CC=CC=2)C2=C3C=CC(C=C3OC3=CC(=CC=C32)N2CC3=CC=CC=C3C2)=[N+]2CC3=CC=CC=C3C2)CCC1C(=O)ON1C(=O)CCC1=O MTVVRWVOXZSVBW-UHFFFAOYSA-M 0.000 description 8
- 230000002438 mitochondrial effect Effects 0.000 description 8
- 230000009467 reduction Effects 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 230000008859 change Effects 0.000 description 7
- 229960000956 coumarin Drugs 0.000 description 7
- 235000001671 coumarin Nutrition 0.000 description 7
- 230000003247 decreasing effect Effects 0.000 description 7
- 230000003111 delayed effect Effects 0.000 description 7
- 238000013461 design Methods 0.000 description 7
- 239000000975 dye Substances 0.000 description 7
- 230000007717 exclusion Effects 0.000 description 7
- 238000010839 reverse transcription Methods 0.000 description 7
- 108020004682 Single-Stranded DNA Proteins 0.000 description 6
- 238000013459 approach Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 101710163270 Nuclease Proteins 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 238000011901 isothermal amplification Methods 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000035772 mutation Effects 0.000 description 5
- 230000010355 oscillation Effects 0.000 description 5
- 238000006116 polymerization reaction Methods 0.000 description 5
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 4
- 241000582786 Monoplex Species 0.000 description 4
- 238000007846 asymmetric PCR Methods 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 238000007403 mPCR Methods 0.000 description 4
- 229910001629 magnesium chloride Inorganic materials 0.000 description 4
- 238000011897 real-time detection Methods 0.000 description 4
- UDGUGZTYGWUUSG-UHFFFAOYSA-N 4-[4-[[2,5-dimethoxy-4-[(4-nitrophenyl)diazenyl]phenyl]diazenyl]-n-methylanilino]butanoic acid Chemical compound COC=1C=C(N=NC=2C=CC(=CC=2)N(C)CCCC(O)=O)C(OC)=CC=1N=NC1=CC=C([N+]([O-])=O)C=C1 UDGUGZTYGWUUSG-UHFFFAOYSA-N 0.000 description 3
- 102100022524 Alpha-1-antichymotrypsin Human genes 0.000 description 3
- 108091023037 Aptamer Proteins 0.000 description 3
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 3
- 101000678026 Homo sapiens Alpha-1-antichymotrypsin Proteins 0.000 description 3
- 108020005196 Mitochondrial DNA Proteins 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000003366 endpoint assay Methods 0.000 description 3
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 3
- 239000007850 fluorescent dye Substances 0.000 description 3
- 238000012933 kinetic analysis Methods 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 241000709661 Enterovirus Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000003149 assay kit Methods 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 238000004590 computer program Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000001351 cycling effect Effects 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 238000010223 real-time analysis Methods 0.000 description 2
- 238000003375 selectivity assay Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- 101000940067 Arabidopsis thaliana Coronatine-insensitive protein 1 Proteins 0.000 description 1
- 101100020619 Arabidopsis thaliana LATE gene Proteins 0.000 description 1
- 101710132601 Capsid protein Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 101710094648 Coat protein Proteins 0.000 description 1
- 108010075028 Cytochromes b Proteins 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 108020001019 DNA Primers Proteins 0.000 description 1
- 229940123014 DNA polymerase inhibitor Drugs 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 1
- 102100036243 HLA class II histocompatibility antigen, DQ alpha 1 chain Human genes 0.000 description 1
- 108010086786 HLA-DQA1 antigen Proteins 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 101710125418 Major capsid protein Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 101710141454 Nucleoprotein Proteins 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 101710083689 Probable capsid protein Proteins 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 241000589500 Thermus aquaticus Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N adenyl group Chemical group N1=CN=C2N=CNC2=C1N GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 230000003281 allosteric effect Effects 0.000 description 1
- 238000012197 amplification kit Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 239000002509 fulvic acid Substances 0.000 description 1
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000001046 green dye Substances 0.000 description 1
- 239000004021 humic acid Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000011880 melting curve analysis Methods 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000007425 progressive decline Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000012207 quantitative assay Methods 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000010396 two-hybrid screening Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20256509P | 2009-03-12 | 2009-03-12 | |
| US61/202,565 | 2009-03-12 | ||
| PCT/US2010/027011 WO2010105074A1 (en) | 2009-03-12 | 2010-03-11 | Reagents and methods for pcr |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2755207A1 true CA2755207A1 (en) | 2010-09-16 |
Family
ID=42244601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2755207A Abandoned CA2755207A1 (en) | 2009-03-12 | 2010-03-11 | Reagents and methods for pcr |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US9034605B2 (OSRAM) |
| EP (2) | EP2703501A1 (OSRAM) |
| JP (1) | JP5757885B2 (OSRAM) |
| CN (1) | CN102421918B (OSRAM) |
| AU (1) | AU2010224100B2 (OSRAM) |
| CA (1) | CA2755207A1 (OSRAM) |
| WO (1) | WO2010105074A1 (OSRAM) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8980561B1 (en) | 2006-08-22 | 2015-03-17 | Los Alamos National Security, Llc. | Nucleic acid detection system and method for detecting influenza |
| WO2008105814A2 (en) | 2006-08-22 | 2008-09-04 | Los Alamos National Security, Llc | Miniturized lateral flow device for rapid and sensitive detection of proteins or nucleic acids |
| CA2723536C (en) | 2008-05-05 | 2017-06-13 | Los Alamos National Security, Llc | Highly simplified lateral flow-based nucleic acid sample preparation and passive fluid flow control |
| CA2755207A1 (en) * | 2009-03-12 | 2010-09-16 | Brandeis University | Reagents and methods for pcr |
| CN103459612A (zh) * | 2010-12-03 | 2013-12-18 | 布兰代斯大学 | 用于检测野生型群体中的核酸突变体的方法和试剂盒 |
| KR101878889B1 (ko) | 2011-04-20 | 2018-07-16 | 메사 바이오테크, 인크. | 핵산의 왕복 증폭 반응 |
| JP2015508655A (ja) * | 2012-02-14 | 2015-03-23 | コーネル ユニバーシティー | 組み合わせたヌクレアーゼ反応、連結反応、およびポリメラーゼ反応を用いて核酸配列、発現、またはコピー変化を相対的に定量するための方法 |
| HK1217517A1 (zh) * | 2013-01-23 | 2017-01-13 | Brandeis University | 用於提高pcr准确度的试剂 |
| KR102126031B1 (ko) * | 2013-07-23 | 2020-07-08 | 삼성전자주식회사 | 유전적 변이를 함유하는 핵산 검출 방법 |
| CN105378160B (zh) * | 2013-08-12 | 2018-04-17 | 伯乐生命医学产品有限公司 | 具有碱基配对的寡聚体的扩增报告子 |
| US20160222434A1 (en) * | 2013-09-13 | 2016-08-04 | Brandeis University | Modified Polymerase Compositions, Methods and Kits |
| US10240178B2 (en) | 2014-12-19 | 2019-03-26 | Brandeis University | Mispriming prevention reagents |
| SG10202005427PA (en) | 2015-04-24 | 2020-07-29 | Mesa Biotech Inc | Fluidic test cassette |
| CA2994601C (en) * | 2015-08-06 | 2020-08-25 | F. Hoffmann-La Roche Ag | Target enrichment by single probe primer extension |
| US10730030B2 (en) | 2016-01-08 | 2020-08-04 | Bio-Rad Laboratories, Inc. | Multiple beads per droplet resolution |
| CN109601008B (zh) * | 2016-04-01 | 2023-02-28 | 克罗玛科德公司 | 用于工程化信号产生的竞争性探针 |
| CN107541508A (zh) * | 2016-06-24 | 2018-01-05 | 广州康昕瑞基因健康科技有限公司 | 模板‑引物核酸分子、聚合酶活性测定方法及试剂盒 |
| CN108774639B (zh) * | 2018-05-31 | 2023-05-30 | 澳門帝傑數碼基因有限公司 | 一种定向聚合的荧光探针pcr |
| EP3818170A4 (en) * | 2018-07-02 | 2022-03-09 | Swift Biosciences, Inc. | Temperature controlled dna polymerase inhibitors |
| US20220307066A1 (en) * | 2019-06-14 | 2022-09-29 | University Of Washington | An enzymatic assay to measure long-term adherence to pre exposure prophylaxis and antiretroviral therapy |
| CN114341150B (zh) * | 2019-06-25 | 2025-01-14 | 生物辐射实验室股份有限公司 | 用于增强逆转录酶活性和/或减少逆转录酶抑制的组合物和方法 |
| EP4107264A4 (en) * | 2020-02-21 | 2024-06-05 | Mission Bio, Inc. | Enhanced detection of target nucleic acids by removal of dna-rna cross contamination |
| JP7209980B2 (ja) * | 2020-12-11 | 2023-01-23 | 東洋紡株式会社 | Ｄｎａポリメラーゼの５’→３’エキソヌクレアーゼ活性ドメインに特異的に結合する抗体 |
| CN115747328A (zh) * | 2022-08-19 | 2023-03-07 | 福建师范大学 | 一种提高单链dna产量和改善产物比例的方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US5066584A (en) | 1988-09-23 | 1991-11-19 | Cetus Corporation | Methods for generating single stranded dna by the polymerase chain reaction |
| US5210015A (en) | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| US5994056A (en) | 1991-05-02 | 1999-11-30 | Roche Molecular Systems, Inc. | Homogeneous methods for nucleic acid amplification and detection |
| US5338671A (en) | 1992-10-07 | 1994-08-16 | Eastman Kodak Company | DNA amplification with thermostable DNA polymerase and polymerase inhibiting antibody |
| US5925517A (en) | 1993-11-12 | 1999-07-20 | The Public Health Research Institute Of The City Of New York, Inc. | Detectably labeled dual conformation oligonucleotide probes, assays and kits |
| US20050242506A1 (en) | 1994-07-22 | 2005-11-03 | Shuffle Master, Inc. | Poker game variation with variable size wagers and play against a pay table |
| AU726844B2 (en) | 1995-06-07 | 2000-11-23 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligands that bind to and inhibit DNA polymerases |
| US5773258A (en) | 1995-08-25 | 1998-06-30 | Roche Molecular Systems, Inc. | Nucleic acid amplification using a reversibly inactivated thermostable enzyme |
| WO1997039008A1 (en) | 1996-04-12 | 1997-10-23 | The Public Health Research Institute Of The City Of New York, Inc. | Detection probes, kits and assays |
| US6277607B1 (en) | 1999-05-24 | 2001-08-21 | Sanjay Tyagi | High specificity primers, amplification methods and kits |
| US7198897B2 (en) | 2001-12-19 | 2007-04-03 | Brandeis University | Late-PCR |
| AU2004227353B2 (en) * | 2003-04-01 | 2010-02-25 | Luminex Corporation | Polymerase inhibitor and method of using same |
| US8916503B2 (en) * | 2004-02-18 | 2014-12-23 | Chromocell Corporation | Methods and materials using signaling probes |
| CN101076608B (zh) * | 2004-10-18 | 2013-04-17 | 布兰迪斯大学 | 在pcr扩增中提高再现性和降低引物错导的试剂和方法 |
| ES2529204T3 (es) * | 2004-10-18 | 2015-02-17 | Brandeis University | Métodos para la amplificación de ácido nucleico |
| AU2006269282B2 (en) | 2005-07-07 | 2013-10-24 | Quanta Biosciences, Inc. | Compositions and methods for increasing amplification efficiency |
| DE602006008150D1 (de) * | 2006-10-12 | 2009-09-10 | Bio Rad Pasteur | Doppelsträngige Sonden zur Fluoreszenzdetektion von Nukleinsäuren |
| EA201101361A1 (ru) * | 2006-12-14 | 2012-11-30 | Новартис Аг | Композиции и способы, предназначенные для лечения мышечных и сердечно-сосудистых нарушений |
| CA2755207A1 (en) | 2009-03-12 | 2010-09-16 | Brandeis University | Reagents and methods for pcr |
-
2010
- 2010-03-11 CA CA2755207A patent/CA2755207A1/en not_active Abandoned
- 2010-03-11 JP JP2011554206A patent/JP5757885B2/ja not_active Expired - Fee Related
- 2010-03-11 AU AU2010224100A patent/AU2010224100B2/en not_active Ceased
- 2010-03-11 US US13/256,038 patent/US9034605B2/en active Active
- 2010-03-11 CN CN201080020170.6A patent/CN102421918B/zh not_active Expired - Fee Related
- 2010-03-11 WO PCT/US2010/027011 patent/WO2010105074A1/en not_active Ceased
- 2010-03-11 EP EP13195156.8A patent/EP2703501A1/en not_active Withdrawn
- 2010-03-11 EP EP10708682.9A patent/EP2406394B1/en not_active Not-in-force
-
2015
- 2015-05-18 US US14/715,299 patent/US9758813B2/en active Active
-
2017
- 2017-09-08 US US15/698,992 patent/US20180002739A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010105074A1 (en) | 2010-09-16 |
| CN102421918A (zh) | 2012-04-18 |
| JP2012520080A (ja) | 2012-09-06 |
| US9034605B2 (en) | 2015-05-19 |
| US20150322503A1 (en) | 2015-11-12 |
| AU2010224100B2 (en) | 2015-10-22 |
| CN102421918B (zh) | 2016-01-20 |
| US20120088275A1 (en) | 2012-04-12 |
| US9758813B2 (en) | 2017-09-12 |
| JP5757885B2 (ja) | 2015-08-05 |
| US20180002739A1 (en) | 2018-01-04 |
| AU2010224100A1 (en) | 2011-10-27 |
| EP2406394A1 (en) | 2012-01-18 |
| EP2703501A1 (en) | 2014-03-05 |
| EP2406394B1 (en) | 2014-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2010224100B2 (en) | Reagents and methods for PCR | |
| AU2018260633B2 (en) | Compositions and methods for improving sample identification in indexed nucleic acid libraries | |
| US8252558B2 (en) | Methods for amplifying and detecting nucleic acid sequences | |
| US20090226973A1 (en) | Reagents and methods for improving reproducibility and reducing mispriming in PCR amplification | |
| CN103459612A (zh) | 用于检测野生型群体中的核酸突变体的方法和试剂盒 | |
| CN106566855B (zh) | 使用可逆修饰寡核苷酸扩增核酸 | |
| US20200032310A1 (en) | Mispriming prevention reagents | |
| Liu et al. | Invading stacking primer: A trigger for high-efficiency isothermal amplification reaction with superior selectivity for detecting microRNA variants | |
| EP2841598B1 (en) | Method for competitive allele-specific cdna synthesis and differential amplification of the cdna products | |
| EP4143335A1 (en) | Exponential base-3 and greater nucleic acid amplification with cycling probe | |
| CA3220607A1 (en) | Methods and compositions related to cooperative primers and reverse transcription | |
| JP2008528021A (ja) | 生化学試薬及びその使用 | |
| JP2021514637A (ja) | 特異性を改善した核酸を増幅する方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20150311 |
|
| FZDE | Dead |
Effective date: 20170313 |